EGR1 and metabolic dysfunction-associated steatotic liver disease: Non‐alcoholic steatohepatitis (NASH) proceeds NAFLD in the progression of HCC and initial characteristics of NASH include insulin resistance resulting from elevated EGR1 expression in response to long‐term HFD.55